Cystic Fibrosis Lung: Clinical Trials

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	1	Completed 1
Phase 2	1	Completed 1

Follow Cystic Fibrosis Lung: new trials by email Literature Review of Cystic Fibrosis Lung trials Research Report on Cystic Fibrosis Lung

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection RSP-1502, Tobramycin inhalation solution - Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic	Phase 1 / Phase 2	Completed	Respirion Pharmaceuticals Pty Ltd	71	2024-04-01	2026-06-25

Narrower conditions

Bronchiolitis Obliterans Syndrome (1)  ·  Cystic Fibrosis (1)  ·  Pseudomonas Infections (1)  ·  Recurrence (1)  ·  Respiratory Tract Infections (1)

Broader conditions

Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Bronchial Diseases (1)  ·  Bronchiolitis (1)  ·  Bronchiolitis Obliterans (1)  ·  Bronchitis (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Disease Attributes (1)  ·  Genetic Diseases, Inborn (1)  ·  Graft vs Host Disease (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Immune System Diseases (1)  ·  Infant, Newborn, Diseases (1)  ·  Infections (1)

Sponsors

Respirion Pharmaceuticals Pty Ltd (1)

Countries

Australia (1)  ·  United States (1)